FDA approves Myqorzo for symptomatic obstructive hypertrophic cardiomyopathy

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...

Treatment for rheumatic mitral stenosis depends on damage

At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to help the ...
IEEE

VAE-Driven Multimodal Fusion for Early Cardiac Disease Detection

Abstract: This study presents a novel multimodal deep learning model designed to improve early detection and diagnosis of chronic cardiac conditions such as Severe Left Ventricular Hypertrophy (SLVH) ...
IEEE

CSD-AFNet: Computationally Efficient Atrial Fibrillation Classification from ECGs using 2D Causal Strided Dilated Convolutions

Automated analysis of electrocardiogram (ECG) signals using deep learning (DL) methods has shown substantial promise in atrial fibrillation (AFib) classification, particularly for detecting subtle ...
TCTMD

Year in Review: EARLY TAVR, Tricuspid Nuance, Mitral Gains, and More

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.
Tribune Content Agency on MSN

Ask the doctors: Treatment for rheumatic mitral stenosis depends on damage

At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to help the ...